Human epidermal growth factor receptor 2 (HER2)–positive breast cancer, defined as HER2 gene amplification and/or protein overexpression, occurs in approximately 20% of primary breast cancers and corresponds to a clinically aggressive subtype (3, 4). This evidence concerns the gene ERBB2 and breast carcinoma.